Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was "taking these difficult but necessary ...

The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but necessary ...

Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...

In April 2023, 23andMe was targeted in a hack that exposed the personal data of 6.9 million customers. The company agreed to ...

Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...

The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the ...

As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.

In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...